➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Moodys
Baxter
Harvard Business School
Mallinckrodt

Last Updated: May 15, 2021

DrugPatentWatch Database Preview

OLANZAPINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Olanzapine patents expire, and when can generic versions of Olanzapine launch?

Olanzapine is a drug marketed by Am Regent, Aurobindo Pharma Ltd, Sandoz Inc, Ajanta Pharma Ltd, Apotex Inc, Barr Labs Inc, Dr Reddys Labs Ltd, Hec Pharm, Hisun Pharm Hangzhou, Invagen Pharms, Jubilant Generics, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Par Pharm, Sun Pharm Inds, Torrent Pharms Llc, Alkem Labs Ltd, Hikma, Indoco, Ivax Pharms Inc, Jiangsu Hansoh Pharm, Qilu, Sunshine, Teva Pharms, Torrent Pharms Ltd, Zydus Pharms, and Sandoz. and is included in forty-three NDAs.

The generic ingredient in OLANZAPINE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.

Drug patent expirations by year for OLANZAPINE
Drug Prices for OLANZAPINE

See drug prices for OLANZAPINE

Drug Sales Revenue Trends for OLANZAPINE

See drug sales revenues for OLANZAPINE

Recent Clinical Trials for OLANZAPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
HCA Hospice CarePhase 2
Tan Tock Seng HospitalPhase 3
Amani Hassan Abdel-WahabPhase 1/Phase 2

See all OLANZAPINE clinical trials

Pharmacology for OLANZAPINE
Paragraph IV (Patent) Challenges for OLANZAPINE
Tradename Dosage Ingredient NDA Submissiondate
ZYPREXA ZYDIS TABLET, ORALLY DISINTEGRATING;ORAL olanzapine 021086
ZYPREXA TABLET;ORAL olanzapine 020592

US Patents and Regulatory Information for OLANZAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd OLANZAPINE olanzapine TABLET;ORAL 202295-003 Oct 20, 2015 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou OLANZAPINE olanzapine TABLET;ORAL 206924-002 Dec 31, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Macleods Pharms Ltd OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 203044-002 Feb 20, 2015 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Invagen Pharms OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 203456-001 Mar 16, 2016 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Torrent Pharms Ltd OLANZAPINE olanzapine TABLET;ORAL 091434-006 Apr 23, 2012 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Teva Pharms OLANZAPINE olanzapine TABLET;ORAL 076000-001 Oct 24, 2011 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Baxter
Boehringer Ingelheim
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.